Ex­clu­sive: mR­NA start­up Turn Biotech­nolo­gies ac­quires Vesi­gen’s mi­crovesi­cle de­liv­ery tech

Turn Biotech­nolo­gies, a start­up de­vel­op­ing mR­NA ther­a­pies to wind back the clock on ag­ing cells has ac­quired an ex­per­i­men­tal drug de­liv­ery tech­nol­o­gy from Har­vard Uni­ver­si­ty …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER